Kreon Travix Max Aktywnosci Lipolitycznej (Pancreas Powder)

Kreon Travix Max Aktywnosci Lipolitycznej, a pancreatic enzyme replacement, is used to manage conditions involving exocrine pancreatic insufficiency.

• Cystic Fibrosis: Improves digestion and nutrient absorption in patients with pancreatic insufficiency due to cystic fibrosis.
• Chronic Pancreatitis: Reduces steatorrhea and supports nutritional status in chronic pancreatitis with enzyme deficiency.
• Post‑Pancreatic Surgery: Assists digestion after surgical removal of pancreatic tissue.

• Pancreas Powder contains a blend of lipase, amylase, and protease enzymes that mimic natural pancreatic secretions. After oral administration, the enzymes are released in the small intestine where they hydrolyze dietary fats, carbohydrates, and proteins, facilitating their absorption. By supplementing deficient endogenous enzymes, the preparation compensates for impaired pancreatic exocrine function.

Pancreas Powder may cause adverse reactions, ranging from mild to serious.

Common Side Effects

• Abdominal discomfort: mild pain or cramping in the abdomen.
• Diarrhea: loose stools occurring after dosing.
• Constipation: difficulty passing stools.
• Nausea: feeling of sickness or urge to vomit.
• Flatulence: increased gas production.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, swelling, or anaphylaxis.
• Fibrosing colonopathy: rare intestinal scarring with high-dose long-term use.
• Pancreatitis: inflammation of the pancreas.
• Severe abdominal pain: persistent or worsening pain.
• Respiratory distress: difficulty breathing in rare cases.

When using Pancreas Powder, consider the following precautions to ensure safety and effectiveness.

• Dose adjustment: tailor the enzyme dose to the individual's dietary fat intake and clinical response.
• Monitoring: regularly assess nutritional status and stool fat content.
• Allergies: avoid use in patients with known hypersensitivity to porcine-derived enzymes.
• High‑dose therapy: limit prolonged high doses to reduce risk of fibrosing colonopathy.
• Concomitant medications: inform healthcare provider of antacids or acid‑reducing agents.
• Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Pancreas Powder can interact with certain medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

• Proton pump inhibitors: reduce gastric acidity, potentially decreasing enzyme activation.
• H2‑blockers: may lower enzyme effectiveness for the same reason.
• Antacids containing aluminum or magnesium: can bind enzymes and impair activity.

Moderate Interactions (Monitor Closely)

• Warfarin: monitor INR as enzyme supplements may affect vitamin K absorption.
• Oral contraceptives: observe for potential changes in hormone levels.
• Antibiotics: assess for altered gut flora that could influence digestion.